<!DOCTYPE html>
<html lang="en" class="scroll-smooth">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>TransMedics (TMDX) - TickerHack Deep Research</title>
    <script src="https://cdn.tailwindcss.com"></script>
    <script src="https://cdn.jsdelivr.net/npm/chart.js"></script>
    <link href="https://fonts.googleapis.com/css2?family=Inter:wght@300;400;500;600;700&display=swap" rel="stylesheet">
    <style>
        body {
            font-family: 'Inter', sans-serif;
            background-color: #F5F5F4; /* stone-100 */
            color: #374151; /* gray-700 */
        }
        .chart-container {
            position: relative;
            width: 100%;
            max-width: 600px;
            margin-left: auto;
            margin-right: auto;
            height: 300px;
            max-height: 350px;
        }
        @media (min-width: 768px) { /* md */
            .chart-container {
                height: 350px;
                max-height: 400px;
            }
        }
        .section-card {
            background-color: #FFFFFF;
            border-radius: 0.75rem; /* rounded-xl */
            box-shadow: 0 10px 15px -3px rgba(0, 0, 0, 0.07), 0 4px 6px -2px rgba(0, 0, 0, 0.04); /* Softer shadow */
            padding: 1.5rem; /* p-6 */
            margin-bottom: 2rem; /* mb-8 */
        }
        .main-title {
            font-size: 2.25rem; /* text-4xl */
            font-weight: 700; /* font-bold */
            color: #1F2937; /* gray-800 */
            margin-bottom: 1rem;
            text-align: center;
        }
        .section-title {
            font-size: 1.875rem; /* text-3xl */
            font-weight: 600; /* font-semibold */
            color: #A78BFA; /* violet-400 */
            margin-bottom: 1.5rem; /* mb-6 */
            padding-bottom: 0.5rem; /* pb-2 */
            border-bottom: 2px solid #E7E5E4; /* stone-200 */
        }
        .subsection-title {
            font-size: 1.5rem; /* text-2xl */
            font-weight: 600; /* font-semibold */
            color: #7DD3FC; /* sky-400 */
            margin-top: 1.5rem; /* mt-6 */
            margin-bottom: 1rem; /* mb-4 */
        }
        .content-text {
            line-height: 1.75;
            color: #4B5563; /* gray-600 */
            font-size: 0.95rem;
        }
        .highlight {
            color: #F97316; /* orange-500 */
            font-weight: 600;
        }
        .tab-button {
            padding: 0.5rem 1rem;
            border-radius: 0.375rem; /* rounded-md */
            font-weight: 500;
            font-size: 0.875rem; /* text-sm */
            cursor: pointer;
            transition: background-color 0.3s, color 0.3s;
            background-color: #E7E5E4; /* stone-200 */
            color: #374151; /* gray-700 */
            border: 1px solid transparent;
        }
        .tab-button.active {
            background-color: #A78BFA; /* violet-400 */
            color: #FFFFFF;
            border-color: #8B5CF6; /* violet-500 */
        }
        .nav-link {
            padding: 0.5rem 1rem;
            border-radius: 0.375rem; /* rounded-md */
            font-weight: 500;
            color: #374151; /* gray-700 */
            transition: background-color 0.2s ease-in-out, color 0.2s ease-in-out;
            white-space: nowrap;
        }
        .nav-link:hover, .nav-link.active {
            background-color: #A78BFA; /* violet-400 */
            color: #FFFFFF;
        }
        .kpi-card {
            background-color: #F9FAFB; /* gray-50 */
            border: 1px solid #E7E5E4; /* stone-200 */
            border-radius: 0.5rem; /* rounded-lg */
            padding: 1rem;
            text-align: center;
        }
        .kpi-label {
            font-size: 0.875rem; /* text-sm */
            color: #6B7280; /* gray-500 */
            margin-bottom: 0.25rem;
        }
        .kpi-value {
            font-size: 1.75rem; /* text-2xl or 3xl */
            font-weight: 600;
            color: #1F2937; /* gray-800 */
        }
    </style>
</head>
<body class="min-h-screen">

    <header class="sticky top-0 z-50 bg-white/95 backdrop-blur-md shadow-md">
        <nav class="container mx-auto px-4 sm:px-6 lg:px-8">
            <div class="flex items-center justify-between h-16">
                <div class="flex-shrink-0">
                    <h1 class="text-xl font-bold" style="color: #A78BFA;">TransMedics (TMDX) Analysis</h1>
                </div>
                <div class="hidden md:block">
                    <div class="ml-10 flex items-baseline space-x-1 lg:space-x-2">
                        <a href="#overview" class="nav-link">Overview</a>
                        <a href="#segments" class="nav-link">Business Model</a>
                        <a href="#financials" class="nav-link">Financials</a>
                        <a href="#competition" class="nav-link">Competitive Moat</a>
                        <a href="#outlook" class="nav-link">Outlook</a>
                    </div>
                </div>
                <div class="md:hidden">
                    <button id="mobile-menu-button" type="button" class="inline-flex items-center justify-center p-2 rounded-md text-gray-500 hover:text-gray-700 hover:bg-gray-100 focus:outline-none focus:ring-2 focus:ring-inset focus:ring-violet-500" aria-controls="mobile-menu" aria-expanded="false">
                        <span class="sr-only">Open main menu</span>
                        <svg class="block h-6 w-6" xmlns="http://www.w3.org/2000/svg" fill="none" viewBox="0 0 24 24" stroke="currentColor" aria-hidden="true"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M4 6h16M4 12h16M4 18h16" /></svg>
                        <svg class="hidden h-6 w-6" xmlns="http://www.w3.org/2000/svg" fill="none" viewBox="0 0 24 24" stroke="currentColor" aria-hidden="true"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M6 18L18 6M6 6l12 12" /></svg>
                    </button>
                </div>
            </div>
            <div class="md:hidden hidden" id="mobile-menu">
                <div class="px-2 pt-2 pb-3 space-y-1 sm:px-3">
                    <a href="#overview" class="nav-link block text-base">Overview</a>
                    <a href="#segments" class="nav-link block text-base">Business Model</a>
                    <a href="#financials" class="nav-link block text-base">Financials</a>
                    <a href="#competition" class="nav-link block text-base">Competitive Moat</a>
                    <a href="#outlook" class="nav-link block text-base">Outlook</a>
                </div>
            </div>
        </nav>
    </header>

    <main class="container mx-auto p-4 md:p-6 lg:p-8 mt-4">

        <section id="overview" class="section-card scroll-mt-20">
            <h2 class="section-title">TransMedics: The New Standard of Care in Organ Transplant</h2>
            <p class="content-text mb-6">TransMedics is a medical technology company transforming organ transplantation through its revolutionary Organ Care System (OCS™). This platform keeps donor organs alive and functioning in a near-physiologic state outside the body, a stark contrast to the traditional method of cold storage ("organ on ice"). The company's primary strategy is to provide this technology as part of a comprehensive service, the <span class="highlight">National OCS Program (NOP)</span>, which manages the entire transplant logistics process for hospitals. This has fueled explosive growth and established TransMedics as a disruptive force aiming to make more life-saving transplants possible.</p>
            
            <div class="grid md:grid-cols-2 gap-6 items-start">
                <div>
                    <h3 class="subsection-title !mt-0">Core Strategy: From Device to Full-Stack Service</h3>
                    <p class="content-text mb-4">TransMedics' go-to-market strategy has evolved to drive deep integration and rapid adoption:</p>
                    <ul class="list-disc list-inside content-text space-y-1 pl-4">
                        <li><strong class="font-semibold text-gray-700">The National OCS Program (NOP):</strong> Providing a "one-call" solution for organ retrieval, preservation, and transport. This removes logistical and clinical burdens from transplant centers, accelerating OCS adoption.</li>
                        <li><strong class="font-semibold text-gray-700">Expanding the Donor Pool:</strong> Utilizing the OCS to make previously marginal organs, especially from donors after circulatory death (DCD), viable for transplant.</li>
                        <li><strong class="font-semibold text-gray-700">Clinical Data Leadership:</strong> Continuously publishing clinical results to establish OCS as the superior standard of care for improving patient outcomes.</li>
                        <li><strong class="font-semibold text-gray-700">Future Growth Platforms:</strong> Investing in next-generation technologies and expanding the OCS platform to new organs, with the kidney being the next major target.</li>
                    </ul>
                </div>
                <div class="kpi-card bg-violet-50 border-violet-200">
                    <p class="kpi-label">Q1 2025 Revenue Growth (YoY)</p>
                    <p class="kpi-value text-violet-600">133%</p>
                    <p class="content-text text-sm mt-2">Demonstrates the massive acceleration in growth driven by the widespread adoption of the National OCS Program across the U.S.</p>
                </div>
            </div>
        </section>

        <section id="segments" class="section-card scroll-mt-20">
            <h2 class="section-title">How TransMedics Makes Money: The OCS Ecosystem</h2>
            <p class="content-text mb-6">TransMedics' revenue is generated entirely from its Organ Care System platform, but is recognized through two distinct streams: the sale of the physical product (disposables) and the revenue from the comprehensive NOP service.</p>

            <div class="mb-6 border-b border-stone-200">
                <nav class="-mb-px flex space-x-4" aria-label="Tabs">
                    <button class="segment-tab-button active" data-target="nop">National OCS Program</button>
                    <button class="segment-tab-button" data-target="product">OCS Products</button>
                </nav>
            </div>

            <div id="segmentDetails">
                <div id="nopContent" class="segment-content">
                    <h3 class="subsection-title">The National OCS Program (NOP)</h3>
                    <div class="grid grid-cols-1 md:grid-cols-2 gap-6">
                        <div>
                            <p class="content-text mb-2">This is the dominant part of TransMedics' business. Under the NOP, the company provides the OCS technology and all associated clinical and logistical services for a comprehensive fee. This has become the preferred model for the majority of U.S. transplant centers.</p>
                             <ul class="list-disc list-inside content-text space-y-1 pl-4 mt-4">
                                <li><strong>Service Revenue:</strong> The fee charged for managing the organ retrieval, including personnel and transportation.</li>
                                <li><strong>Product Revenue:</strong> The revenue recognized from the single-use OCS disposable component used in each NOP case.</li>
                             </ul>
                        </div>
                        <div class="kpi-card bg-sky-50 border-sky-200">
                            <p class="kpi-label">NOP Revenue Mix</p>
                            <p class="kpi-value text-sky-600">>90% of Total</p>
                            <p class="content-text text-sm mt-2">The shift to the NOP service model has been the key catalyst for the company's hyper-growth and market penetration.</p>
                        </div>
                    </div>
                </div>
                <div id="productContent" class="segment-content hidden">
                    <h3 class="subsection-title">OCS Products (Heart, Lung, Liver)</h3>
                     <div class="grid grid-cols-1 md:grid-cols-1 gap-6">
                         <div>
                            <p class="content-text mb-2">The Organ Care System is the core technology. It consists of a portable console and a single-use disposable set specific to each organ. The system perfuses the organ with warm, oxygenated, and nutrient-enriched solution, mimicking the conditions inside the human body and allowing the organ to remain viable for longer periods.</p>
                        </div>
                    </div>
                </div>
            </div>
        </section>

        <section id="financials" class="section-card scroll-mt-20">
            <h2 class="section-title">Financial Deep Dive</h2>
            <p class="content-text mb-6">TransMedics is experiencing a period of explosive growth, as shown by its triple-digit revenue increases. The company has also achieved profitability on both a GAAP and Adjusted EBITDA basis, demonstrating the scalability and high-margin nature of its service-oriented business model.</p>
            
            <div class="grid grid-cols-1 md:grid-cols-2 gap-8">
                <div>
                    <h3 class="subsection-title">Fiscal Year Trends (FY22-FY24)</h3>
                    <div class="mb-4">
                        <label for="yearlyMetricSelect" class="block text-sm font-medium text-gray-700 mb-1">Select Annual Metric:</label>
                        <select id="yearlyMetricSelect" class="block w-full p-2 border border-stone-300 rounded-md shadow-sm focus:ring-violet-500 focus:border-violet-500">
                            <option value="totalRevenue" selected>Total Revenue ($M)</option>
                            <option value="grossMargin">Gross Margin (%)</option>
                            <option value="adjEbitda">Adjusted EBITDA ($M)</option>
                        </select>
                    </div>
                    <div id="yearlyFinancialChartContainer" class="chart-container h-80 max-w-full">
                        <canvas id="yearlyFinancialChart"></canvas>
                    </div>
                </div>

                <div>
                    <h3 class="subsection-title">Quarterly Trends (Recent 8 Qtrs)</h3>
                     <div class="mb-4">
                        <label for="quarterlyMetricSelect" class="block text-sm font-medium text-gray-700 mb-1">Select Quarterly Metric:</label>
                        <select id="quarterlyMetricSelect" class="block w-full p-2 border border-stone-300 rounded-md shadow-sm focus:ring-violet-500 focus:border-violet-500">
                             <option value="totalRevenue" selected>Total Revenue ($M)</option>
                             <option value="grossMargin">Gross Margin (%)</option>
                             <option value="adjEbitda">Adjusted EBITDA ($M)</option>
                        </select>
                    </div>
                    <div id="quarterlyFinancialChartContainer" class="chart-container h-80 max-w-full">
                        <canvas id="quarterlyFinancialChart"></canvas>
                    </div>
                </div>
            </div>
             <p class="content-text text-sm mt-6 text-center">The financial charts showcase a dramatic ramp in revenue and a strong improvement in profitability, reflecting the successful execution of the NOP strategy.</p>
        </section>

        <section id="competition" class="section-card scroll-mt-20">
            <h2 class="section-title">Competitive Moat: A First-Mover Fortress</h2>
            <p class="content-text mb-6">TransMedics has built a formidable competitive moat by being the first and only company to commercialize a warm perfusion platform for multiple organs, and then wrapping it in a comprehensive, high-touch service model.</p>
            
            <div class="grid md:grid-cols-2 gap-8">
                <div>
                    <h3 class="subsection-title !mt-0">Key Moats</h3>
                    <ul class="list-none space-y-3">
                        <li class="flex items-start">
                            <span class="text-violet-500 mr-2 mt-1">➔</span>
                            <span class="content-text"><strong class="text-gray-700">Regulatory Barrier:</strong> As the only company with FDA approvals for warm perfusion of heart, lung, and liver, TransMedics has a significant regulatory head start. Any potential competitor would need to conduct lengthy and expensive clinical trials.</span>
                        </li>
                        <li class="flex items-start">
                            <span class="text-violet-500 mr-2 mt-1">➔</span>
                            <span class="content-text"><strong class="text-gray-700">The NOP Service Network:</strong> The National OCS Program creates very high switching costs. Hospitals are not just buying a device; they are outsourcing their entire organ retrieval logistics to a trusted partner, making it difficult for a new entrant to displace them.</span>
                        </li>
                        <li class="flex items-start">
                            <span class="text-violet-500 mr-2 mt-1">➔</span>
                            <span class="content-text"><strong class="text-gray-700">Proprietary Technology & Data:</strong> The OCS platform is protected by strong patents, and the vast amount of clinical and logistical data collected through thousands of transplants provides an ongoing advantage in optimizing the service.</span>
                        </li>
                    </ul>
                </div>
                <div>
                    <h3 class="subsection-title !mt-0">Primary Competitors</h3>
                     <ul class="list-none space-y-3">
                        <li class="flex items-start">
                            <span class="text-sky-500 mr-2 mt-1">●</span>
                            <span class="content-text"><strong class="text-gray-700">Traditional Cold Storage:</strong> The primary competition remains the long-standing, inexpensive, but less effective method of using an ice cooler. TransMedics' goal is to displace this as the standard of care.</span>
                        </li>
                        <li class="flex items-start">
                            <span class="text-sky-500 mr-2 mt-1">●</span>
                            <span class="content-text"><strong class="text-gray-700">Other Perfusion Technologies:</strong> Companies like OrganOx (private) and XVIVO Perfusion are competitors, particularly in the liver and lung space and primarily outside the U.S. However, none currently offer the multi-organ platform and integrated service model of TransMedics in the U.S.</span>
                        </li>
                    </ul>
                </div>
            </div>
        </section>

        <section id="outlook" class="section-card scroll-mt-20">
            <h2 class="section-title">Strategic Outlook: Risks & Rewards</h2>
            <p class="content-text mb-6">TransMedics is a hyper-growth company single-handedly creating a new market. The opportunity is immense, but the path forward requires flawless execution and navigating the challenges of scaling a complex, life-saving service.</p>
            <div class="grid md:grid-cols-2 gap-8">
                <div>
                    <h3 class="subsection-title !mt-0 text-teal-600">Rewards & Opportunities 🚀</h3>
                    <ul class="list-disc list-inside content-text space-y-2 pl-4">
                        <li><strong>Massive Addressable Market:</strong> The potential to significantly increase the number of transplantable organs represents a multi-billion dollar market opportunity in the U.S. alone.</li>
                        <li><strong>OCS Kidney Development:</strong> The kidney transplant market is significantly larger than heart, lung, and liver combined. A successful OCS Kidney platform would be a transformative catalyst for future growth.</li>
                        <li><strong>International Expansion:</strong> Replicating the successful U.S. NOP model in international markets presents another major growth vector.</li>
                        <li><strong>Operating Leverage:</strong> As revenue continues to scale, the company has the potential to generate significant profit growth due to the high-margin nature of its disposables and the efficiencies of its service model.</li>
                    </ul>
                </div>
                <div>
                    <h3 class="subsection-title !mt-0 text-orange-600">Risks & Challenges 📉</h3>
                    <ul class="list-disc list-inside content-text space-y-2 pl-4">
                        <li><strong>Execution Risk:</strong> The NOP is a logistically intensive business. The company's ability to manage its rapid growth, maintain service quality, and control costs is critical.</li>
                        <li><strong>Competition:</strong> While the current moat is strong, the large market opportunity will inevitably attract more competition over the long term, which could pressure growth and margins.</li>
                        <li><strong>Reimbursement Headwinds:</strong> The company's success relies on favorable reimbursement policies from Medicare and private payers. Any negative changes could impact adoption.</li>
                        <li><strong>Concentration:</strong> The business is entirely focused on the OCS platform. While this provides a clear focus, it also means the company's fortunes are tied to a single technology.</li>
                    </ul>
                </div>
            </div>
        </section>

        <footer class="bg-stone-800 text-stone-300 py-8 text-center mt-12">
            <p class="text-sm">&copy; <span id="currentYearFooter"></span> TickerHack Deep Research. For informational purposes only.</p>
            <p class="text-xs mt-1">Data synthesized from TransMedics Group, Inc. public filings and credible financial data providers as of July 2, 2025.</p>
        </footer>

    <script>
        document.getElementById('currentYearFooter').textContent = new Date().getFullYear();

        // Mobile menu toggle
        const mobileMenuBtn = document.getElementById('mobile-menu-button');
        const mobileMenuEl = document.getElementById('mobile-menu');
        mobileMenuBtn.addEventListener('click', () => {
            mobileMenuEl.classList.toggle('hidden');
            mobileMenuBtn.querySelectorAll('svg').forEach(svg => svg.classList.toggle('hidden'));
        });
        
        // Smooth scroll and active nav link highlighting
        const navLinks = document.querySelectorAll('header nav a[href^="#"]');
        navLinks.forEach(link => {
            link.addEventListener('click', (e) => {
                if (mobileMenuEl && !mobileMenuEl.classList.contains('hidden')) {
                    mobileMenuBtn.click(); // Close mobile menu if open
                }
                navLinks.forEach(l => l.classList.remove('active'));
                e.currentTarget.classList.add('active');
            });
        });
        
        // Segment Tabs
        const segmentTabs = document.querySelectorAll('.segment-tab-button');
        const segmentContents = document.querySelectorAll('.segment-content');
        segmentTabs.forEach(tab => {
            tab.addEventListener('click', () => {
                segmentTabs.forEach(t => t.classList.remove('active'));
                tab.classList.add('active');
                const targetId = tab.dataset.target + 'Content';
                segmentContents.forEach(content => {
                    content.id === targetId ? content.classList.remove('hidden') : content.classList.add('hidden');
                });
            });
        });

        // Chart.js Global Config
        Chart.defaults.font.family = "'Inter', sans-serif";
        Chart.defaults.color = '#4B5563';

        const CHART_COLORS = {
            violet: '#A78BFA',
            sky: '#7DD3FC',
            orange: '#FDBA74',
            teal: '#5EEAD4'
        };
        

        // --- FINANCIAL CHARTS LOGIC ---

        // Yearly Data Store (Fiscal Years end Dec 31)
        const yearlyDataStore = {
            labels: ['FY22', 'FY23', 'FY24'],
            totalRevenue: { data: [93.9, 241.5, 439.1], label: 'Total Revenue ($M)', color: CHART_COLORS.violet },
            grossMargin: { data: [65, 69, 71], label: 'Gross Margin (%)', color: CHART_COLORS.sky },
            adjEbitda: { data: [-32.5, 4.4, 45.1], label: 'Adjusted EBITDA ($M)', color: CHART_COLORS.orange }
        };

        // Quarterly Data Store
        const quarterlyDataStore = {
            labels: ['Q2 23', 'Q3 23', 'Q4 23', 'Q1 24', 'Q2 24', 'Q3 24', 'Q4 24', 'Q1 25'],
            totalRevenue: { data: [51.5, 66.4, 78.9, 96.9, 110.1, 115.3, 116.8, 122.2], label: 'Total Revenue ($M)', color: CHART_COLORS.violet },
            grossMargin: { data: [68, 69, 70, 70, 71, 71, 72, 72], label: 'Gross Margin (%)', color: CHART_COLORS.sky },
            adjEbitda: { data: [1.2, 5.7, 12.0, 12.3, 15.6, 17.0, 18.9, 21.0], label: 'Adjusted EBITDA ($M)', color: CHART_COLORS.orange }
        };

        let yearlyChart = null;
        let quarterlyChart = null;
        const yearlySelect = document.getElementById('yearlyMetricSelect');
        const quarterlySelect = document.getElementById('quarterlyMetricSelect');
        const yearlyCanvas = document.getElementById('yearlyFinancialChart').getContext('2d');
        const quarterlyCanvas = document.getElementById('quarterlyFinancialChart').getContext('2d');

        function createChart(canvas, existingChart, dataStore, metricKey) {
            if (existingChart) {
                existingChart.destroy();
            }
            const metricDetails = dataStore[metricKey];
            const isEbitda = metricKey === 'adjEbitda';
            const isMargin = metricKey === 'grossMargin';
            
            const chartType = isMargin ? 'line' : 'bar';
            const chartData = metricDetails.data;
            const chartLabel = metricDetails.label;
            
            let backgroundColor;
            if (isMargin) {
                backgroundColor = 'transparent';
            } else if (isEbitda) {
                backgroundColor = chartData.map(value => value >= 0 ? CHART_COLORS.teal + 'BF' : CHART_COLORS.orange + 'BF');
            } else {
                backgroundColor = metricDetails.color + 'BF';
            }

            let borderColor;
            if (isEbitda) {
                borderColor = chartData.map(value => value >= 0 ? CHART_COLORS.teal : CHART_COLORS.orange);
            } else {
                borderColor = metricDetails.color;
            }

            return new Chart(canvas, {
                type: chartType,
                data: {
                    labels: dataStore.labels,
                    datasets: [{
                        label: chartLabel,
                        data: chartData,
                        backgroundColor: backgroundColor,
                        borderColor: borderColor,
                        borderWidth: 2,
                        fill: !isMargin
                    }]
                },
                options: {
                    responsive: true,
                    maintainAspectRatio: false,
                    scales: { 
                        y: { 
                            beginAtZero: true, 
                            title: { display: true, text: chartLabel.split('(')[1].replace(')','') }
                        } 
                    },
                    plugins: { 
                        legend: { display: false },
                        tooltip: {
                            callbacks: {
                                label: function(context) {
                                    let label = context.dataset.label || '';
                                    if (label) {
                                        label += ': ';
                                    }
                                    if (context.parsed.y !== null) {
                                       label += context.parsed.y + (isMargin ? '%' : 'M');
                                    }
                                    return label;
                                }
                            }
                        }
                    }
                }
            });
        }
        
        yearlySelect.addEventListener('change', (event) => {
            yearlyChart = createChart(yearlyCanvas, yearlyChart, yearlyDataStore, event.target.value);
        });

        quarterlySelect.addEventListener('change', (event) => {
            quarterlyChart = createChart(quarterlyCanvas, quarterlyChart, quarterlyDataStore, event.target.value);
        });

        // Initial chart renders
        yearlyChart = createChart(yearlyCanvas, yearlyChart, yearlyDataStore, 'totalRevenue');
        quarterlyChart = createChart(quarterlyCanvas, quarterlyChart, quarterlyDataStore, 'totalRevenue');

    </script>
</body>
</html>

